A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis
Year: 1998
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Bone Marrow Transplantation
Institutions: St Vincent's Hospital Sydney, Amgen (Australia)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Amgen Australia
OpenAlex ID: W2098487604
